Clinical trial

Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

NCT06012656

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention MiniMAX Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2019-01-02

PhaseN/A

Conditions

Primary Osteoarthritisunresolved

Secondary Osteoarthritisunresolved

Traumatic Arthritisunresolved

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Congenital Hip Dysplasiaverified · MONDO: developmental dysplasia of the hip

Avascular Necrosisverified · MONDO: avascular necrosis

Fracture; Femur, Headunresolved

Interventions

MiniMAXDEVICE

Sponsors & collaborators

Medacta International SAlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06012656 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.